Skip to main content
SpringerLink
Log in

New Directions in Immunopharmacotherapy

  • Conference paper
The Role of Natural Products in Drug Discovery

Part of the book series: Ernst Schering Research Foundation Workshop ((SCHERING FOUND,volume 32))

  • 219 Accesses

Abstract

The application of antibodies for immunotherapy was documented as early as 1890 (von Behring and Kitasato 1890). In the past, polyclonal antibodies found in antiserum against specific antigens were used in passive immunization strategies to combat infectious diseases such as hepatitis B and HIV (Sawyer et al. 1998; Jacobson 1998). While this approach has merit, it is hampered by several unwanted side effects, including the risk of viral contamination, serum sickness, anaphylaxis (nonhuman serum) and, importantly, the difficulty of making standardized batches of antibody to insure reproducibility and proper dosing. A milestone was reached when the production of homogeneous monoclonal antibodies (mAbs) with defined specificity and high affinity became a reality through hybridoma technology, developed by Köhler and Milstein in 1975. As a result, thousands of mAbs against different antigens have been generated and used in a wide variety of biological studies. Additionally, hybridoma technology ushered in the concept of replacing polyclonal antibodies with mAbs as therapeutic drugs (Coons 1995; Scott and Welt 1997; Vaswani and Hamilton 1998). Indeed, with well-defined specificity and better reproducibility, mAbs have been touted as “magic bullets” in the fight against disease. Our research efforts have been aimed at utilizing antibodies, both in passive administration and as generated in vivo by an immune response, for cancer treatment and in the treatment of cocaine abuse. We describe the details and directions of our immunopharmacological studies in these areas.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Apostolopoulos V, McKenzie IFC (1994) Cellular mucins: targets for immunotherapy. Crit Rev Immunol 14:293–309

    Article  PubMed  CAS  Google Scholar 

  • Bagasra O, Forman LJ, Howeedy A, Whittle P (1992) A potential vaccine for cocaine abuse prophylaxis. Immunopharmacology 23:173–179

    Article  PubMed  CAS  Google Scholar 

  • Barbas CF III (1994) The combinatorial approach to human antibodies. In: Rosenberg M, Moore GP (eds) The pharmacology of monoclonal antibodies. Springer, Berlin Heidelberg New York, pp 242–266 (Handbook of experimental pharmacology, vol 113)

    Google Scholar 

  • Barbas CF III, Kang AS, Lerner RA, Benkovic SJ (1991) Assembly of combinatorial antibody libraries on phage surfaces: the gene III site. Proc Natl Acad Sei U S A 88:7978–7982

    Article  CAS  Google Scholar 

  • Barbas CF III, Bain JD, Hoekstra DM, Lerner RA (1992) Semisynthetic combinatorial antibody libraries: a chemical solution to the diversity problem. Proc Natl Acad Sei U S A 89:4457–4461

    Article  CAS  Google Scholar 

  • Barnett G, Hawks R, Resnick R (1981) Cocaine pharmacokinetics in humans. J Ethnopharmacol 3:353–366

    Article  PubMed  CAS  Google Scholar 

  • Bender E, Pilkington GR, Burton DR (1994) Human monoclonal Fab fragments from a combinatorial library prepared from an individual with a low serum titer to a virus. Human Antibod Hybrid 5:3–8

    CAS  Google Scholar 

  • Berg EL, Robinson MK, Mansson O, Butcher EC, Magnani JL (1991) A carbohydrate domain common to both sialyl Lea and sialyl Lex is recognized by the endothelial cell leukocyte adhesion molecule ELAM-1. J Biol Chem 266:14869–14872

    PubMed  CAS  Google Scholar 

  • Berkowitz B, Spector S (1972) Evidence for active immunity to morphine in mice. Science 178:1290–1292

    Article  PubMed  CAS  Google Scholar 

  • Bhavanandan VP (1991) Cancer-associated mucin and mucin-type glycoprotein. Glycobiology 1:493–503

    Article  PubMed  CAS  Google Scholar 

  • Bird RE, Hardman KD, Jacobson JW, Johnson S, Kaufman BM, Lee SM, Lee T, Pope SH, Riordan GS, Whitlow M (1988) Single-chain antigen-binding proteins. Science 242:423–426

    Article  PubMed  CAS  Google Scholar 

  • Blaine JD, Ling W (1992) Psychopharmacologic treatment of cocaine dependence. Psychopharmacol Bull 28:11–14

    PubMed  CAS  Google Scholar 

  • Boyer CS, Petersen DR (1992) Enzymatic basis for the transesterification of cocaine in the presence of ethanol: evidence for the participation of microsomal carboxylesterases. J Pharmacol Exp Ther 260:939–946

    PubMed  CAS  Google Scholar 

  • Brown SL, Miller RA, Horning SJ, Czerwinski D, Hart SM, McElderry R, Basham T, Warnke RA, Merigan TC, Levy R (1989) Treatment of B-cell lymphomas with anti-idiotype antibodies alone and in combination with alpha interferon. Blood 73:651–661

    PubMed  CAS  Google Scholar 

  • Brzezinski MR, Abraham TL, Stone CL, Dean RA, Bosron WF (1994) Purification and characterization of a human liver cocaine carboxylesterase that catalyzes the cocaine. Biochem Pharmacol 48:1747–1755

    Article  PubMed  CAS  Google Scholar 

  • Burton DR, Barbas CF III (1993a) Human antibodies to HIV-1 by recombinant DNA methods. Chem Immunol 56:112–126

    Article  PubMed  CAS  Google Scholar 

  • Burton DR, Barbas CF III (1993b) Human antibodies from combinatorial libraries. In: Clark M (ed) Protein engineering of antibody molecules for prophylactic and therapeutic applications in man. Academic Titles, Nottingham, pp 65–82

    Google Scholar 

  • Burton DR, Barbas CF III (1994) Human antibodies from combinatorial libraries. Adv Immunol 57:191–280

    Article  PubMed  CAS  Google Scholar 

  • Burton DR, Barbas CF III, Persson MAA, Koenig S, Chanock RM, Lerner RA (1991) A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals. Proc Natl Acad Sei U S A 88:10134–10137

    Article  CAS  Google Scholar 

  • Carrera MRA, Ashley JA, Parsons LH, Wirsching P, Koob GF, Janda KD (1995) Suppression of psychoactive effects of cocaine by active immunization. Nature 378:727–730

    Article  PubMed  CAS  Google Scholar 

  • Carroll KM (1993) Psychotherapeutic treatment of cocaine abuse: Models for its evaluation alone and in combination with pharmacotherapy. NIDA Res Monogr 135:116–132

    PubMed  CAS  Google Scholar 

  • Castro-Palomino JC, Ritter G, Fortunate SR, Reinhardt S, Old LJ, Schmidt RR (1997) Efficient synthesis of ganglioside GM2 for use in cancer vaccines. Angew Chem Int Ed Engl 36:1998–2001

    Article  CAS  Google Scholar 

  • Chaudhary VK, Queen C, Junghans RP, Waldmann TA, FitzGerald DJ, Pastan I (1989) A recombinant immunotoxin consisting of two antibody variable domains fused to Pseudomonas exotoxin. Nature 339:394–397

    Article  PubMed  CAS  Google Scholar 

  • Chester KA, Hawkins RE (1995) Clinical issues in antibody design. Trends Biotechnol 13:294–300

    Article  PubMed  CAS  Google Scholar 

  • Cheung NK, Lazarus H, Miraldi FD, Abramowsky CR, Kallick S, Saarinen UM, Spitzer T, Strandjord SE, Coccia PF, Berger NA (1987) Ganglioside GD2 specific monoclonal antibody 3F8: a phase I study in patients with neuroblastoma and malignant melanoma. J Clin Oncol 5:1430–1440

    PubMed  CAS  Google Scholar 

  • Cheung NK, Kushner BH, Cheung IY, Kramer K, Canete A, Gerald W, Bonilla MA, Finn R, Yeh SJ, Larson SM (1998a) Anti-G(D2) antibody treatment of minimal residual stage 4 neuroblastoma diagnosed at more than 1 year of age. J Clin Oncol 16:3053–3060

    PubMed  CAS  Google Scholar 

  • Cheung NK, Kushner BH, Yeh SDJ, Larson SM (1998b) 3F8 monoclonal antibody treatment of patients with stage 4 neuroblastoma: a phase II study. Int J Oncol 12:1299–1306

    Google Scholar 

  • Co MS, Deschamps M, Whitley RJ, Queen C (1991) Humanized antibodies for antiviral therapy. Proc Natl Acad Sei U S A 88:2869–2873

    Article  CAS  Google Scholar 

  • Co MS, Avdalovic NM, Caron PC, Avdalovic MV, Scheinberg DA, Queen C (1992) Chimeric and humanized antibodies with specificity for the CD33 antigen. J Immunol 148:1149–1154

    PubMed  CAS  Google Scholar 

  • Co MS, Baker J, Bednarik K, Janzek E, Neruda W, Mayer P, Plot R, Stumper B, Vasquez M, Queen C, Loibner H (1996) Humanized anti-Lewis Y antibodies: in vitro properties and pharmacokinetics in rhesus monkeys. Cancer Res 56:1118–1125

    PubMed  CAS  Google Scholar 

  • Coons T (1995) Monoclonal antibodies: the promise and the reality. Radiol Technol 67:39–60

    PubMed  CAS  Google Scholar 

  • Crameri A, Raillard SA, Bermudez E, Stemmer WP (1998) DNA shuffling of a family of genes from diverse species accelerates directed evolution. Nature 391:288–291

    Article  PubMed  CAS  Google Scholar 

  • Cregler LL, Herbert M (1986) Medical complications of cocaine abuse. N Engl J Med 315:1495–1500

    Article  PubMed  CAS  Google Scholar 

  • Crowe JE jr, Murphy BR, Chanock RM, Williamson RA, Barbas CF III, Burton DR (1994) Recombinant human respiratory syncytial virus (RSV) monoclonal antibody Fab is effective therapeutically when introduced directly into the lungs of RSV-infected mice. Proc Natl Acad Sei U S A 91:1386–1390

    Article  CAS  Google Scholar 

  • Cunningham KA, Lakoski JM (1990) The interaction of cocaine serotonin dorsal raphe neurons. Single-unit extracellular recording studies. Neuropsycho-pharmacology 3:41–50

    CAS  Google Scholar 

  • Dean RA, Christian CD, Sample B, Bosron WF (1991) Human liver cocaine esterases: ethanol-mediated formation of ethylcocaine. FASEB J 5:2735–2739

    PubMed  CAS  Google Scholar 

  • DeNardo SJ, DeNardo GL, O’Grady LF, Hu E, Sytsma VM, Mills SL, Levy NB, Macey DJ, Miller CH, Epstein AL (1988) Treatment of B cell malignancies with II Lym-1 monoclonal antibodies. Int J Cancer [Suppl] 3:96–101

    Google Scholar 

  • Des Jarlais DC, Friedland SR (1989) AIDS and IV drug use. Science 245:578–579

    Article  PubMed  Google Scholar 

  • Dickman S (1998) Antibodies stage a comeback in cancer treatment. Science 280:1196–1197

    Article  PubMed  CAS  Google Scholar 

  • Dillman RO, Beauregard J, Shawler DL, Halpern SE, Markman M, Ryan KP, Baird SM, Clutter M (1986) Continuous infusion of T101 monoclonal antibody in chronic lymphocytic leukemia and cutaneous T-cell lymphoma. J Biol Response Mod 5:394–410

    PubMed  CAS  Google Scholar 

  • Dillman RO, Shawler DL, Dillman JB, Royston I (1984) Therapy of chronic lymphocytic leukemia and cutaneous T-cell lymphoma with T101 monoclonal antibody. J Clin Oncol 2:881–891

    PubMed  CAS  Google Scholar 

  • Dillman RO, Beauregard JC, Halpern SE, Clutter M (1986) Toxicities and side effects associated with intravenous infusions of murine monoclonal antibodies. J Biol Response Mod 5:73–84

    PubMed  CAS  Google Scholar 

  • Dyer MJ, Hale G, Hayhoe FG, Waldmann H (1989) Effects of CAMPATH-1 antibodies in vivo in patients with lymphoid malignancies: influence of antibody isotype. Blood 73:1431–1439

    PubMed  CAS  Google Scholar 

  • Eisen HN (1964) Equilibrium dialysis for measurement of antibody-hapten affinities. In: Eisen HN (ed) Methods in medical research. Yearbook Medical Publishers, Chicago, pp 106–114

    Google Scholar 

  • Foon KA, Schroff RW, Bunn PA, Mayer D, Abrams PG, Fer M, Ochs J, Bottino GC, Sherwin SA, Carlo DJ, et al (1984) Effects of monoclonal anti- body therapy in patients with chronic lymphocytic leukemia. Blood 64:1085–1093

    PubMed  CAS  Google Scholar 

  • Frank DA, Zuckerman B, Amaro H, Aboagye K, Bauchner H, Cabrai H, Freid L, Hingson R, Kayne H, Levenson SM, Parker S, Reece H, Vinci R (1988) Cocaine use during pregnancy: prevalence and correlates. Pediatrics 82:888–895

    PubMed  CAS  Google Scholar 

  • Frost JD, Hank JA, Reaman GH, Frierdich S, Seeger RC, Gan J, Anderson PM, Ettinger LJ, Cairo MS, Blazar BR, Krailo MD, Matthay KK, Reisfeld RA, Sondel PM (1997) A phase I/IB trial of murine monoclonal anti-GD2 antibody 14, G2a plus interleukin-2 in children with refractory neuroblastoma: a report of the Children’s Cancer Group. Cancer 80:317–333

    Article  PubMed  CAS  Google Scholar 

  • Fukushima K, Hirota M, Terasaki PI, Wakisaka A, Togashi H, Chia D, Suyama N, Fukushi Y, Nudelman E, Hakomori S (1984) Characterization of sialosy-lated Lewis x as a new tumor-associated antigen. Cancer Res 44:5279–5285

    PubMed  CAS  Google Scholar 

  • Furukawa K, Yamaguchi H, Oettgen HF, Old LJ, Lloyd KO (1989) Two human monoclonal antibodies reacting with the major gangliosides of human melanomas and comparison with corresponding mouse monoclonal antibodies. Cancer Res 49:191–196

    PubMed  CAS  Google Scholar 

  • Gallacher G (1994) A potential vaccine for cocaine abuse prophylaxis? Immu-nopharmacology 27:79–81

    CAS  Google Scholar 

  • Gao C, Lavey BJ, Lo CHL, Datta A, Wentworth P, Janda KD (1997a) Direct selection for catalysis from combinatorial antibody libraries using a boronic acid probe: primary amide bond hydrolysis. J Am Chem Soc 120:2211–2217

    Article  Google Scholar 

  • Gao C, Lin C-H, Lo C-HL, Mao S, Wirsching P, Lerner RA, Janda KD (1997b) Making chemistry selectable by linking it to infectivity. Proc Natl Acad Sei U S A 94:11777–11782

    Article  CAS  Google Scholar 

  • Garrett ER, Seyda K (1983) Prediction of stability in pharmaceutical preparations XX: stability evaluation and bioanalysis of cocaine and ben-zoylecgonine by high-performance liquid chromatography. J Pharm Sei 72:258–271

    Article  CAS  Google Scholar 

  • Gijsen HJM, Qiao L, Fitz W, Wong C-H (1996) Recent advances in the chemoenzymatic synthesis of carbohydrates and carbohydrate mimetics. Chem Rev 96:443–173

    Article  PubMed  CAS  Google Scholar 

  • Goldenberg DM, Horowitz JA, Sharkey RM, Hall TC, Murthy S, Goldenberg H, Lee RE, Stein R, Siegel JA, Izon DO, et al (1991) Targeting dosimetry and radioimmunotherapy of B-cell lymphomas with iodine-131-labeled LL2 monoclonal antibody (see comments). J Clin Oncol 9:548–564

    PubMed  CAS  Google Scholar 

  • Gray WH (1925) Aromatic esters of acylecgonines. J Chem Soc 128:1150–1158

    Google Scholar 

  • Grossbard ML, Press OW, Appelbaum FR, Bernstein ID, Nadler LM (1992) Monoclonal antibody-based therapies of leukemia and lymphoma. Blood 80:863–878

    PubMed  CAS  Google Scholar 

  • Grossbard ML, Freedman AS, Ritz J, Coral F, Goldmacher VS, Eliseo L, Spec-tor N, Dear K, Lambert JM, Blattler WA, et al (1992) Serotherapy of B-cell neoplasms with anti-B4-blocked ricin: a phase I trial of daily bolus infusion. Blood 79:576–585

    PubMed  CAS  Google Scholar 

  • Hakomori S (1986) Glycosphingolipids. Sei Am 254:44–53

    CAS  Google Scholar 

  • Hakomori S (1989) Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens. Adv Cancer Res 52:257–331

    Article  PubMed  CAS  Google Scholar 

  • Hakomori S (1996) Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. Cancer Res 56:5309–5318

    PubMed  CAS  Google Scholar 

  • Hakomori S, Zhang Y (1997) Glycosphingolipid antigens and cancer therapy. Chem Biol 4:97–104

    Article  PubMed  CAS  Google Scholar 

  • Hill JH, Wainer BH, Fitch FW, Rothberg RM (1973) The interaction of 14C-morphine with sera from immunized rabbits and from patients addicted to heroin. Clin Exp Immunol 15:213–224

    PubMed  CAS  Google Scholar 

  • Hoffman JA, Caudill BD, Koman JJ III, Luckey JW, Flynn PM, Hubbard RL (1994) Comparative cocaine abuse treatment strategies: Enhancing client retention and treatment exposure. J. Addict Dis 13:115–128

    Article  PubMed  CAS  Google Scholar 

  • Hounsell EF, Young M, Davies MJ (1997) Glycoprotein changes in tumours: a renaissance in clinical applications. Clin Sei 93:87–293

    Google Scholar 

  • Huston JS, Levinson D, Mudgett-Hunter M, Tai MS, Novotny J, Margolies MN, Ridge RJ, Bruccoleri RE, Haber E, Créa R, Oppermann H (1988) Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli. Proc Natl Acad Sei U S A 85:5879–5883

    Article  CAS  Google Scholar 

  • Imbach P (ed) (1991) Immunotherapy with intravenous immunoglobulins. Academic, San Diego

    Google Scholar 

  • Irie RF, Matsuki T, Morton DL (1989) Human monoclonal antibody to gan-glioside GM2 for melanoma treatment. Lancet 1:786

    Article  PubMed  CAS  Google Scholar 

  • Ito M, Suzuki E, Naiki M, Sendo F, Arai S (1984) Carbohydrates as tumor-associated antigens. Int J Cancer 34:689–697

    Article  PubMed  CAS  Google Scholar 

  • Jacobson JM (1998) Passive immunization for the treatment of HIV infection. Mt Sinai J Med 65:22–26

    PubMed  CAS  Google Scholar 

  • James K (1994) Human monoclonal antibodies. In: Rosenberg M, Moore GP (eds) The Pharmacology of Monoclonal Antibodies. Springer, Berlin Heidelberg New York, pp 3–19 (Handbook of experimental pharmacology, vol 113)

    Chapter  Google Scholar 

  • Janda KD, Lo CH, Li T, Barbas CF III, Wirsching P, Lerner RA (1994) Direct selection for a catalytic mechanism from combinatorial antibody libraries. Proc Natl Acad Sei U S A 91:2532–2536

    Article  CAS  Google Scholar 

  • Janda KD, Lo LC, Lo CHL, Sim MM, Wang R, Wong CH, Lerner RA (1997) Chemical selection for catalysis in combinatorial antibody libraries. Science 275:945–948

    Article  PubMed  CAS  Google Scholar 

  • Jones PT, Dear PH, Foote J, Neuberger MS, Winter G (1986) Replacing the complementarity-determining regions in a human antibody with those from a mouse. Nature 321:522–525

    Article  PubMed  CAS  Google Scholar 

  • Kang AS, Barbas CF III, Janda KD, Benkovic SJ, Lerner RA (1991) Linkage of recognition and replication functions by assembling combinational antibody Fab libraries along phage surfaces. Proc Natl Acad Sei U S A 88:4363–4366

    Article  CAS  Google Scholar 

  • Kehrl JH, Muraguchi A, Butler JL, Falkoff RJM, Fauci AS (1984) Human B cell activation proliferation and differentiation. Immunol Rev 78:75–96

    Article  PubMed  CAS  Google Scholar 

  • Khazaeli MB, Saleh MN, Wheeler RH, Huster WJ, Holden H, Carrano R, LoBuglio AF (1988) Phase I trial of multiple large doses of murine monoclonal antibody CO 17–1 A. II: Pharmacokinetics and immune response. J Natl Cancer Inst 80:937–942

    Article  PubMed  CAS  Google Scholar 

  • Kim YS, Gum J jr, Brockhausen I (1996) Mucin glycoproteins in neoplasia. Glycoconj J 13:693–707

    Article  PubMed  CAS  Google Scholar 

  • Klinman NR, Doughty RA (1973) Hapten-specific stimulation of secondary B cells independent of T cells. J Exp Med 138:473–478

    Article  PubMed  CAS  Google Scholar 

  • Klonoff DC, Andres BT, Obana WG (1989) Stroke associated with cocaine use. Arch Neurol 46:989–993

    Article  PubMed  CAS  Google Scholar 

  • Köhler G, Milstein C (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:495–497

    Article  PubMed  Google Scholar 

  • Kudryashov V, Kim HM, Ragupathi G, Danishefsky SJ, Livingston PO, Lloyd KO (1998) Immunogenicity of synthetic conjugates of Lewis(y) oligosaccharide with proteins in mice: towards the design of anticancer vaccines. Cancer Immunol Immunother 45:281–286

    Article  PubMed  CAS  Google Scholar 

  • Lee JH, Bennett G (1991) Substance abuse in adulthood. In: Bennett G, Woolf D (eds) Substance abuse: pharmacologic developmental and clinical perspectives. Delman, Albany, New York, pp 157–170

    Google Scholar 

  • Lerner RA, Kang AS, Bain JD, Barbas CF III (1992) Antibodies without immunization. Science 258:1313–1314

    Article  PubMed  CAS  Google Scholar 

  • Lewin AH, Gao Y, Abraham P, Boja JW, Kuhar MJ, Carroll FI (1992) 2bb-sub-stituted analogues of cocaine. Synthesis and inhibition of binding to the cocaine receptor. J Med Chem 35:135–140

    Article  PubMed  CAS  Google Scholar 

  • Liu Y, Budd RD, Griesemer EC (1982) Study of the stability of cocaine and benzoylecgonine its major metabolite in blood samples. J Chromatogr 248:318–320

    Article  PubMed  CAS  Google Scholar 

  • Lloyd KO (1993) Tumor antigens known to be immunogenic in man. Ann NY Acad Sei 690:50–58

    Article  CAS  Google Scholar 

  • LoBuglio AF, Saleh MN (1992a) Advances in monoclonal antibody therapy of cancer. Am J Med Sei 304:214–224

    Article  Google Scholar 

  • LoBuglio AF, Saleh MN (1992b) Monoclonal antibody therapy of cancer. Crit Rev Oncol Hematol 13:271–282

    Article  Google Scholar 

  • LoBuglio AF, Wheeler RH, Trang J, Haynes A, Rogers K, Harvey EB, Sun L, Ghrayeb J, Khazaeli MB (1989) Mouse/human chimeric monoclonal antibody in man: kinetics and immune response. Proc Natl Acad Sei USA 86:4220–4224

    Article  Google Scholar 

  • MacLennan ICM, Gray D (1986) Antigen-driven selection of virgin and memory B cells. Immunol Rev 91:61–85

    Article  PubMed  CAS  Google Scholar 

  • Mallender WD, Voss EW jr (1994) Construction expression and activity of a bivalent bispecific single-chain antibody. J Biol Chem 269:199–206

    PubMed  CAS  Google Scholar 

  • Maloney DG, Grillo-Lopez AJ, White CA, Bodkin D, Schilder RJ, Neidhart JA, Janakiraman N, Foon KA, Liles TM, Dallaire BK, Wey K, Royston I, Davis T, Levy R (1997) IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin’s lymphoma. Blood 90:2188–2195

    PubMed  CAS  Google Scholar 

  • Mao S, Gao C, Lo C-HL, Wirsching P, Wong C-H, Janda KD (1999) Phage-display library selection of high affinity human single-chain antibodies to tumor-associated carbohydrate antigens sialyl Lewisx and Lewisx. Proc Natl Acad Sei U S A 96:6953–6958

    Article  CAS  Google Scholar 

  • Mao S, Gao C, Lo C-HL, Janda KD (2000) A human Fab against cholera toxin B from a combinatorial library, (in preparation)

    Google Scholar 

  • Marks C, Marks JD (1996) Phage libraries - a new route to clinically useful antibodies. N Engl J Med 335:730–733

    Article  PubMed  CAS  Google Scholar 

  • Marwick C (1997) Monoclonal antibody to treat lymphoma. JAMA 278:616–618

    Article  PubMed  CAS  Google Scholar 

  • Matsubara K, Kagawa M, Fukui Y (1984) In vivo and in vitro studies on cocaine metabolism: Ecgonine methyl ester as a major metabolite of cocaine. Forensic Sei Intl 26:169–180

    Article  CAS  Google Scholar 

  • Miller RA, Oseroff AR, Stratte PT, Levy R (1983) Monoclonal antibody therapeutic trials in seven patients with T-cell lymphoma. Blood 62:988–995

    PubMed  CAS  Google Scholar 

  • Minden P, Fair RS (1967) The ammonium sulphate method to measure antigen-binding capacity. In: Weir DM (ed) Handbook of experimental immunology, chap 13. Davis, Philadelphia, pp 463–492

    Google Scholar 

  • Möller E (1974) Specificity of hapten-reactive T and B mouse lymphocytes. Affinity and avidity of T- and B-cell receptors and anti-hapten antibodies as factors of dose and time after immunization. Scand J Immunol 3:339–355

    Article  PubMed  Google Scholar 

  • Morrison SL (1985) Transfectomas provide novel chimeric antibodies. Science 229:1202–1207

    Article  PubMed  CAS  Google Scholar 

  • Muramatsu T (1993) Carbohydrate signals in metastasis and prognosis of human carcinomas. Glycobiology 3:294–296

    Article  Google Scholar 

  • Muroi K, Suda T, Nojiri H, Ema H, Amemiya Y, Miura Y, Nakauchi H, Singhal A, Hakomori S (1992) Reactivity profiles of leukemic myeloblasts with monoclonal antibodies directed to sialosyl-Le(x) and other lacto-series type 2 chain antigens: absence of reactivity with normal hematopoietic progenitor cells. Blood 79:713–719

    PubMed  CAS  Google Scholar 

  • National Institute on Drug Abuse Division of Epidemiology and Prevention (1991) Research National Household Survey on Drug Abuse: population estimates 1990. US Department of Health and Human Services, Rockville MD

    Google Scholar 

  • Oettgen HF, Old LJ (1991) In: De Vita V, Hellman S, Rosenberg SA (eds) Biologic therapy of cancer. Lippincott, Philadelphia

    Google Scholar 

  • Oldham RK (1991) Custom-tailored drug immunoconjugates in cancer therapy. Mol Biother 3:148–162

    PubMed  CAS  Google Scholar 

  • Padlan EA (1991) A possible procedure for reducing the immunogenicity of antibody variable domains while preserving their ligand-binding properties. Mol Immunol 28:489–498

    Article  PubMed  CAS  Google Scholar 

  • Pegram MD, Lipton A, Hayes DF, Weber BL, Baselga JM, Tripathy D, Baly D, Baughman SA, Twaddell T, Glaspy JA, Slamon DJ (1998) Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-pi 85HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment. J Clin Oncol 16:2659–2671

    PubMed  CAS  Google Scholar 

  • Pei XY, Holliger P, Murzin AG, Williams RL (1997) The 2,0-Â resolution crystal structure of a trimeric antibody fragment with noncognate VH-VL domain pairs shows a rearrangement of VH CDR3. Proc Natl Acad Sei U S A 94:9637–9642

    Article  CAS  Google Scholar 

  • Phillips ML, Nudelman E, Gaeta FC, Perez M, Singhal AK, Hakomori S, Paulson JC (1990) ELAM-1 mediates cell adhesion by recognition of a carbohydrate ligand sialyl-Lex. Science 250:1130–1132

    Article  PubMed  CAS  Google Scholar 

  • Pietersz G A, Krauer K, McKenzie IFC (1994) The use of monoclonal antibody immunoconjugates in cancer therapy. Adv Exp Med Biol 353:169–179

    Article  PubMed  CAS  Google Scholar 

  • Pike BL, Alderson MR, Nossal GJV (1987) T-independent activation of single B cells: an orderly analysis of overlapping stages in the activation pathway. Immunol Rev 99:120–152

    Article  Google Scholar 

  • Poljak RJ (1994) Production and structure of diabodies. Structure 2:1121–1123

    Article  PubMed  CAS  Google Scholar 

  • Press OW, Eary JF, Badger CC, Martin PJ, Appelbaum FR, Levy R, Miller R, Brown S, Nelp WB, Krohn KA, et al (1989) Treatment of refractory non-Hodgkin’s lymphoma with radiolabeled MB-1 (anti-CD37) antibody. J Clin Oncol 7:1027–1038

    PubMed  CAS  Google Scholar 

  • Ragupathi G, Park TK, Zhang S, Kim IJ, Graber L, Adluri S, Lloyd KO, Dan-ishefsky S J, Livingston PO (1997) Immunization of mice with a fully syn-thetic globo H antigen results in antibodies against human cancer cells: a combined chemical-immunological approach to the fashioning of an anticancer vaccine. Angew Chem Int Ed Engl 36:125–128

    Article  CAS  Google Scholar 

  • Reisfeld RA, Gillies SD (1996) Recombinant antibody fusion proteins for cancer immunotherapy. Curr Top Mircrobiol Immunol 213:27–53

    Article  CAS  Google Scholar 

  • Riechmann L, Clark M, Waldmann H, Winter G (1988) Reshaping human antibodies for therapy. Nature 332:323–327

    Article  PubMed  CAS  Google Scholar 

  • Riethmiiller G, Schneider-Gadicke E, Johnson JP (1993) Monoclonal antibodies in cancer therapy. Curr Opin Immunol 5:732–739

    Article  Google Scholar 

  • Riethmiiller G, Schneider-Gädicke E, Schlimok G, Schmiegel W, Raab R, Hof-fken K, Gruber R, Pichlmaier H, Hirche H, Pichlmayr R, Buggisch P, Witte J (1994) Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes’ C colorectal carcinom. Lancet 343:1177–1183

    Article  Google Scholar 

  • Ritz J, Pesando JM, Sallan SE, Clavell LA, Notis-McConarty J, Rosenthal P, Schlossman SF (1981) Serotherapy of acute lymphoblastic leukemia with monoclonal antibody. Blood 58:141–152

    PubMed  CAS  Google Scholar 

  • Robertson D (1998) Genentech’s anticancer Mab expected by November. Nat Biotechnol 16:615

    Article  PubMed  CAS  Google Scholar 

  • Rosen ST, Zimmer AM, Goldman-Leikin R, Gordon LI, Kazikiewicz JM, Kaplan EH, Variakojis D, Marder RJ, Dykewicz MS, Piergies A, et al (1987) Radioimmunodetection and radioimmunotherapy of cutaneous T cell lymphomas using an 11-labeled monoclonal antibody: an Illinois Cancer Council Study. J Clin Oncol 5:562–573

    PubMed  CAS  Google Scholar 

  • Sames D, Chen X-T, Danishefsky S J (1997) Convergent total synthesis of a tumour-associated mucin motif. Nature 389:587–590

    Article  PubMed  CAS  Google Scholar 

  • Sasaki K, Watanabe E, Kawashima K, Sekine S, Dohi T, Oshima M, Hanai N, Nishi T, Hasegawa M (1993) Expression cloning of a novel Galbb(l-3/1–4)GlcNAc aa-23- sialyltransferase using lectin resistance selection. J Biol Chem 268:22782–22787

    PubMed  CAS  Google Scholar 

  • Sawyer RG, McGory RW, Gaffey MJ, McCullough CC, Shephard BL, Houl-grave CW, Ryan TS, Kuhns M, McNamara A, Caldwell SH, Abdulkareem A, Pruett TL (1998) Improved clinical outcomes with liver transplantation for hepatitis B-induced chronic liver failure using passive immunization. Ann Surg 227:841–850

    Article  PubMed  CAS  Google Scholar 

  • Schneider-Gädicke E, Riethmiiller G (1995) Prevention of manifest metastasis with monoclonal antibodies: a novel approach to immunotherapy of solid tumours. Eur J Cancer 31 A: 1326–1330

    Google Scholar 

  • Scott AM, Welt S (1997) Antibody-based immunological therapies. Curr Opin Immunol 9:717–722

    Article  PubMed  CAS  Google Scholar 

  • Seeberger PH, Bilodeau MT, Danishefsky SJ (1997) Synthesis of biologically important oligosaccharides and other glycoconjugates by the glycal assembly method. Aldrichim Acta 30:75–92

    CAS  Google Scholar 

  • Spector S, Berkowitz B, Flynn EJ, Peskar B (1973) Antibodies to morphine barbiturates and serotonin. Pharmacol Rev 25:281–291

    PubMed  CAS  Google Scholar 

  • Stemmer WP (1994) Rapid evolution of a protein in vitro by DNA shuffling. Nature 370:389–391

    Article  PubMed  CAS  Google Scholar 

  • Sterk C (1988) Cocaine and HIV seropositivity. Lancet 2:1052–1053

    Article  Google Scholar 

  • Steward MW, Steensgaard J (1983) Antibody affinity: thermodynamic aspects and biological significance. CRC Press, Boca Raton

    Google Scholar 

  • Stewart DJ, Inaba T, Lucassen M, Kalow W (1979) Cocaine metabolism: cocaine and norcocaine hydrolysis by liver and serum esterases. Clin Pharmacol Ther 25:464–468

    PubMed  CAS  Google Scholar 

  • Tai T, Paulson JC, Cahan LD, Irie RF (1983) Ganglioside GM2 as a human tumor antigen (OFA-I-1). Proc Natl Acad Sei U S A 80:5392–5396

    Article  CAS  Google Scholar 

  • Takada A, Ohmori K, Yoneda T, Tsuyuoka K, Hasegawa A, Kiso M, Kannagi R (1993) Contribution of carbohydrate antigens sialyl Lewis A and sialyl Lewis X to adhesion of human cancer cells to vascular endothelium. Cancer Res 53:354–361

    PubMed  CAS  Google Scholar 

  • Takayama S, Wong C-H (1997) Chemo-enzymatic approach to carbohydrate recognition. Curr Org Chem 1:109–126

    CAS  Google Scholar 

  • Taussig MJ (1973) Antigenic competition. Curr Top Microbiol Immunol 60:125–174

    Article  PubMed  CAS  Google Scholar 

  • Thirion S, Motmans K, Heyligen H, Janssens J, Raus J, Vandevyver C (1996) Mono- and bispecific single-chain antibody fragments for cancer therapy. Eur J Cancer Prev 5:507–511

    PubMed  CAS  Google Scholar 

  • Tonegawa S (1983) Somatic generation of antibody diversity. Nature 302:575

    Article  PubMed  CAS  Google Scholar 

  • US Department of Health and Human Services (1992) Preliminary estimates from the 1992 Household Survey on Drug Abuse (June 1993) Substance Abuse and Mental Health Service Administration Office of Applied Studies. Washington DC, US Department of Health and Human Services Public Health Services Advance Report, no 3

    Google Scholar 

  • Vaswani SK, Hamilton RG (1998) Humanized antibodies as potential therapeutic drugs. Ann Allergy Asthma Immunol 81:105–115

    Article  PubMed  CAS  Google Scholar 

  • Verhoeyen M, Milstein C, Winter G (1988) Reshaping human antibodies: grafting an antilysozyme activity. Science 239:1534–1536

    Article  PubMed  CAS  Google Scholar 

  • Vitetta ES, Berton MT, Burger C, Kepron M, Lee WT, Yin X-M (1991) Memory B and T cells. Annu Rev Immunol 9:193–217

    Article  PubMed  CAS  Google Scholar 

  • Von Behring E, Kitasato S (1890) Ueber das Zustandekommen der Diphentherie-Immunität und der Tetanus-Immunität bei Thieren. Dtsch Med Wochenschr 16:1113

    Article  Google Scholar 

  • Waldmann TA, Strober W (1969) Metabolism of immunoglobulins. Prog Allergy 13:1–110

    PubMed  CAS  Google Scholar 

  • Wallace BC (1992) Treating crack cocaine dependence: the critical role of relapse prevention. J. Psychoactive Drugs 24:213–222

    Article  PubMed  CAS  Google Scholar 

  • Williamson RA, Burioni R, Sanna PP, Partridge LJ, Barbas CF III, Burton DR (1993) Human monoclonal antibodies against a plethora of viral pathogens from single combinatorial libraries. Proc Natl Acad Sei U S A 90:4141–4145

    Article  CAS  Google Scholar 

  • Wittmann V, Takayama S, Gong K, Weitz-Schmidt G, Wong C (1998) Ligand recognition by E- and P-selectin: chemoenzymatic synthesis and inhibitory activity of bivalent sialyl Lewis x derivatives and sialyl Lewis carboxylic acids. J Org Chem 63:5137–5143

    Article  CAS  Google Scholar 

  • Wong C-H, Halcomb RL, Ichikawa Y, Kajimoto T (1995a) Enzymes in organic synthesis: application to the problems of carbohydrate recognition (part 1). Angew Chem Int Ed Engl 34:412–432

    Article  CAS  Google Scholar 

  • Wong C-H, Halcomb RL, Ichikawa Y, Kajimoto T (1995b) Enzymes in organic synthesis: application to the problems of carbohydrate recognition (part 2). Angew Chem Int Ed Engl 34:521–546

    Article  CAS  Google Scholar 

  • Yamaguchi H, Furukawa K, Fortunato SR, Livingston PO, Lloyd KO, Oettgen HF, Old LJ (1990) Human monoclonal antibody with dual GM2/GD2 specificity derived from an immunized melanoma patient. Proc Natl Acad Sei U S A 87:3333–3337

    Article  CAS  Google Scholar 

  • Yang WP, Green K, Pinz-Sweeney S, Briones AT, Burton DR, Barbas CF III (1995) CDR walking mutagenesis for the affinity maturation of a potent human anti-HIV-1 antibody into the picomolar range. J Mol Biol 254:392–403

    Article  PubMed  CAS  Google Scholar 

  • Yokota T, Milenic DE, Whitlow M, Schlom J (1992) Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms. Cancer Res 52:3402–3408

    PubMed  CAS  Google Scholar 

  • Yu AL, Uttenreuther-Fischer MM, Huang CS, Tsui CC, Gillies SD, Reisfeld RA, Kung FH (1998) Phase I trial of a human-mouse chimeric anti-disia-loganglioside monoclonal antibody chl4,18 in patients with refractory neuroblastoma and osteosarcoma. J Clin Oncol 16:2169–2180

    PubMed  CAS  Google Scholar 

  • Zuckerman B, Frank DA, Hingson R, Amaro H, Levenson SM, Kayne H, Parker S, Vinci R, Aboagye K, Fried LE (1989) Effects of maternal marijuana and cocaine use on fetal growth. N Engl J Med 320:762–768

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. K. D. Janda
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Institut für Organische Chemie, Universität Wien, Währinger Str. 38, 1090, Wien, Austria

    J. Mulzer

  2. Preclinical Drug Research, Schering AG, Müllerstr. 178, 13342, Berlin, Germany

    R. Bohlmann

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Janda, K.D. (2000). New Directions in Immunopharmacotherapy. In: Mulzer, J., Bohlmann, R. (eds) The Role of Natural Products in Drug Discovery. Ernst Schering Research Foundation Workshop, vol 32. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-04042-3_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-04042-3_12

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-04044-7

  • Online ISBN: 978-3-662-04042-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation